Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Catheter Precision (VTAK) Income from Continuing Operations (2017 - 2025)

Catheter Precision has reported Income from Continuing Operations over the past 9 years, most recently at 7658000.0 for Q4 2025.

  • Quarterly Income from Continuing Operations fell 207.92% to 7658000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 21101000.0 through Dec 2025, down 56.28% year-over-year, with the annual reading at 19505000.0 for FY2025, 44.46% down from the prior year.
  • Income from Continuing Operations was 7658000.0 for Q4 2025 at Catheter Precision, down from 2266000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 669000.0 in Q4 2023 and troughed at 66400000.0 in Q1 2023.
  • The 5-year median for Income from Continuing Operations is 5009000.0 (2021), against an average of 7991350.0.
  • Year-over-year, Income from Continuing Operations plummeted 1108.37% in 2023 and then soared 95.97% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 8283000.0 in 2021, then increased by 1.5% to 8159000.0 in 2022, then surged by 91.8% to 669000.0 in 2023, then crashed by 271.75% to 2487000.0 in 2024, then crashed by 207.92% to 7658000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Income from Continuing Operations are 7658000.0 (Q4 2025), 2266000.0 (Q3 2025), and 6408000.0 (Q2 2025).